A case of PLA2R-positive membranous nephropathy with subsequent development of IgG4-related disease

Fumiaki Tanemoto1, Imari Mimura2, Hiroyuki Abe3

  • 1Division of Nephrology and Endocrinology, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-Ku, Tokyo, 113-8655, Japan.

CEN Case Reports
|November 8, 2024
PubMed

Insights

This case study describes a patient with phospholipase A2 receptor (PLA2R)-positive membranous nephropathy (MN) who later developed Immunoglobulin G4-related disease (IgG4-RD). It highlights that IgG4-RD can occur even with PLA2R-positive MN.

Area of Science:

  • Nephrology
  • Immunology
  • Gastroenterology

Background:

  • Membranous nephropathy (MN) is a frequent cause of nephrotic syndrome in adults.
  • MN is a recognized renal manifestation of Immunoglobulin G4-related disease (IgG4-RD).
  • Previously, MN associated with IgG4-RD was typically phospholipase A2 receptor (PLA2R)-negative.

Purpose of the Study:

  • To report the first case of PLA2R-positive MN that subsequently developed IgG4-RD.
  • To discuss the diagnostic challenges in differentiating primary MN from secondary MN in the context of IgG4-RD.
  • To emphasize the importance of considering IgG4-RD in PLA2R-positive MN cases.

Main Methods:

  • Case report of a 60-year-old male diagnosed with nephrotic syndrome.
  • Initial renal biopsy showing PLA2R-positive MN.
  • Follow-up investigations including imaging and biopsies revealing autoimmune pancreatitis and tubulointerstitial nephritis, leading to IgG4-RD diagnosis.

Main Results:

  • The patient presented with PLA2R-positive MN and later developed pancreatic and renal manifestations of IgG4-RD.
  • Treatment with glucocorticoids for IgG4-RD led to remission of autoimmune pancreatitis, renal masses, and MN.
  • This is the first documented case of PLA2R-positive MN preceding the development of IgG4-RD.

Conclusions:

  • The possibility of IgG4-RD should be considered in patients with PLA2R-positive MN.
  • The distinction between primary and secondary MN can be challenging when IgG4-RD is present.
  • This case expands the understanding of the spectrum of renal involvement in IgG4-RD.

Related Concept Videos

Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
259
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
11.9K
Transcytosis of IgG01:15

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
2.7K